Cited by 456Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsBirth, Development, and Health

Trying to understand gestational diabetes

Open access
Catalano, P. M.·2014·Diabetic Medicine

Abstract

Women with normal glucose tolerance pre‐gravid and developing gestational diabetes in late gestation have subclinical metabolic dysfunction prior to conception compared with women with normal glucose tolerance. Because of the 60% decrease in insulin sensitivity with normal pregnancy, these women develop clinical hyperglycaemia/gestational diabetes in late gestation. The metabolic dysfunction includes impaired insulin response, decreased hepatic suppression of glucose production during insulin infusion and decreased insulin‐stimulated glucose uptake in skeletal muscle, i.e. peripheral insulin resistance. The insulin resistance in normal glucose tolerance pregnancy is related to a decrease in the post‐receptor insulin signalling cascade, specifically decreased insulin receptor substrate 1 tyrosine phosphorylation. In women with normal glucose tolerance this is reversed post‐partum. In contrast, in gestational diabetes, in addition to the decrease in insulin receptor substrate 1 tyrosine phosphorylation, there is an additional decrease in tyrosine phosphorylation of the intracellular portion of the insulin receptor that is not related to the insulin receptor protein content. Post‐partum women with gestational diabetes, who had retention of gestational weight gain, had no significant improvement in insulin sensitivity and increased inflammation expressed as increased plasma and skeletal muscle tumour necrosis factor alpha. The increased inflammation or meta‐inflammation is a hallmark of obesity and during pregnancy develops in both white adipose tissue and placenta. Last gene array studies of placenta were associated with alterations in gene expression relating primarily to lipid in contrast to glucose metabolic pathways in gestational diabetes compared with Type 1 diabetes. Future studies are directed at decreasing inflammation prior to and during pregnancy using various lifestyle and nutritional interventions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dme.12381

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Altered expression and/or phosphorylation of IRS-1, PI3K, and GLUT4 has been described in GDM.

    “In addition, altered expression and/or phosphorylation of downstream regulators of insulin signaling, including insulin receptor substrate (IRS)-1, phosphatidylinositol 3-kinase (PI3K), and GLUT4, has been described in GDM [84].”

    From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [84]

    The section “Endogenous glucose production and suppression during pregnancy” (page unavailable) reports reduced IRS-1 protein content and tyrosine phosphorylation in GDM, as well as increased expression of a PI3K regulatory subunit. It does not describe altered GLUT4 expression or phosphorylation; the reported reduction in glucose transport does not establish that part of the claim. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • GDM is associated with upregulated hepatic glucose production (gluconeogenesis).

    “GDM is associated with upregulated hepatic glucose production (gluconeogenesis).”

    From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [84]

    The “Endogenous glucose production and suppression during pregnancy” section (page not available) reports less suppression of hepatic glucose production during insulin infusion in women with GDM. But basal production rose similarly in women with and without GDM, with no significant difference between groups. The passage measures endogenous glucose production; it does not specifically establish increased gluconeogenesis. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • The rate of insulin-stimulated glucose uptake is reduced by 54% in GDM when compared with normal pregnancy.

    “The rate of insulin-stimulated glucose uptake is reduced by 54% in GDM when compared with normal pregnancy [84].”

    From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [84]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [22]22. Desoye G, Hartmann M, Jones CJ, Wolf HJ, Kohnen G, Kosanke G et al. Location of insulin receptors in the placenta and its progenitor tissues. Microsc Res Tech 1997; 38: 36-75.

Cited by

Sorted by citations

Authors
Catalano, P. M.
Affiliations
MetroHealth (US)
Corresponding author
Catalano, P. M.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2014-02-16
Volume
31
Issue
3
Pages
273-281
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2164166774
Cited by
456
References
24
Citations by year
2026: 31 · 2025: 45 · 2024: 37 · 2023: 57 · 2022: 70 · 2021: 61 · 2020: 48 · 2019: 31 · 2018: 23 · 2017: 15 · 2016: 19 · 2015: 12 · 2014: 7
FWCI
14.21
Type
journal article
Language
en
Open access
Locations
  • Diabetic Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Child Health and Human Development (HD 22965-19)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
Keywords
gestational diabetes mellitus, insulin resistance, insulin sensitivity, IRS-1, insulin receptor tyrosine phosphorylation, hepatic glucose production, skeletal muscle glucose uptake, gestational weight gain, inflammation, TNF-α, placental gene expression, lipid metabolism
MeSH terms
Biological Transport, Female, Glucose, Humans, Hyperglycemia, Infant, Newborn, Inflammation, Insulin, Insulin Resistance, Obesity, Phosphorylation, Pregnancy, Prenatal Care, Receptor, Insulin, Signal Transduction, Diabetes, Gestational, Muscle, Skeletal, Receptor Protein-Tyrosine Kinases, Risk Reduction Behavior, Postpartum Period

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review